| Literature DB >> 25815133 |
Keiichi Hishikawa1, Osamu Takase1, Masahiro Yoshikawa1, Taro Tsujimura1, Masaomi Nangaku1, Tsuyoshi Takato1.
Abstract
Human pluripotent cells are promising for treatment for kidney diseases, but the protocols for derivation of kidney cell types are still controversial. Kidney tissue regeneration is well confirmed in several lower vertebrates such as fish, and the repair of nephrons after tubular damages is commonly observed after renal injury. Even in adult mammal kidney, renal progenitor cell or system is reportedly presents suggesting that adult stem-like cells in kidney can be practical clinical targets for kidney diseases. However, it is still unclear if kidney stem cells or stem-like cells exist or not. In general, stemness is defined by several factors such as self-renewal capacity, multi-lineage potency and characteristic gene expression profiles. The definite use of stemness may be obstacle to understand kidney regeneration, and here we describe the recent broad findings of kidney regeneration and the cells that contribute regeneration.Entities:
Keywords: CD133; CD24; ES cell; Induced pluripotent stem; Label-retaining cells; SP cells; Sca-1; Stem cell; rKS56
Year: 2015 PMID: 25815133 PMCID: PMC4369505 DOI: 10.4252/wjsc.v7.i2.490
Source DB: PubMed Journal: World J Stem Cells ISSN: 1948-0210 Impact factor: 5.326